Prognostic models and algorithms in renal cell carcinoma (Q37321015)

19 August 2017

1 reference

title

Prognostic models and algorithms in renal cell carcinoma (English)

1 reference

19 August 2017

0 references

Brian R Lane

1

1 reference

PubMed ID

18992615

19 August 2017

Michael W Kattan

series ordinal

2

1 reference

19 August 2017

1 November 2008

1 reference

Urologic Clinics of North America

19 August 2017

1 reference

19 August 2017

35

1 reference

19 August 2017

4

1 reference

19 August 2017

613-25; vii

1 reference

Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease

19 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Rising incidence of renal cell cancer in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

7 January 2021

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Sunitinib in patients with metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Sorafenib in advanced clear-cell renal-cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Using protein expressions to predict survival in clear cell renal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Evaluating a new marker's predictive contribution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

The changing natural history of renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Symptoms as well as tumor size provide prognostic information on patients with localized renal tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Multi-institutional validation of a symptom based classification for renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Toxicity and response criteria of the Eastern Cooperative Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Improved prognostication of renal cell carcinoma using an integrated staging system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Prognostic factors in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Paraneoplastic Signs and Symptoms of Renal Cell Carcinoma: Implications for Prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Cachexia-like symptoms predict a worse prognosis in localized t1 renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Serum acute phase reactants and prognosis in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Prognostic importance of serum vascular endothelial growth factor in relation to platelet and leukocyte counts in human renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Identification of the genes for kidney cancer: opportunity for disease-specific targeted therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

VHL tumor suppressor gene alterations associated with good prognosis in sporadic clear-cell renal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Genetic and epigenetic alterations in the von hippel-lindau gene: the influence on renal cancer prognosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with > 15-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

A review of prognostic pathologic features and algorithms for patients treated surgically for renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Renal cell carcinoma invading the urinary collecting system: implications for staging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Multifocal renal cell tumors: a retrospective analysis of 56 patients treated with radical nephrectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Prognostic value of multifocality on progression and survival in localized renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Surgical management and prognosis of renal cell carcinoma invading the vena cava

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Prognostic value of microscopic venous invasion in renal cell carcinoma: long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Microvascular tumour invasion in renal cell carcinoma: the most important prognostic factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Preoperative nomogram predicting 12-year probability of metastatic renal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Clinical and pathologic tumor size in renal cell carcinoma; difference, correlation, and analysis of the influencing factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

A preoperative clinical prognostic model for non-metastatic renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

A POSTOPERATIVE PROGNOSTIC NOMOGRAM PREDICTING RECURRENCE FOR PATIENTS WITH CONVENTIONAL CLEAR CELL RENAL CELL CARCINOMA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Expression profiling of human renal carcinomas with functional taxonomic analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Microarray gene expression profiling and analysis in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Differential gene expression in renal-cell cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

CD70: a new tumor specific biomarker for renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

A molecular classification of papillary renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Statistical methods for analyzing tissue microarray data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Serum insulin-like growth factor-1 is an independent predictor of prognosis in patients with renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Expression of survivin in renal cell carcinomas: association with pathologic features and clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Biological significance of p27 and Skp2 expression in renal cell carcinoma. A systematic analysis of primary and metastatic tumour tissues using a tissue microarray technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

VASCULAR ENDOTHELIAL GROWTH FACTOR AS PROGNOSTIC FACTOR IN RENAL CELL CARCINOMA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

VEGF and VEGFR-1 are coexpressed by epithelial and stromal cells of renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Potential histologic and molecular predictors of response to temsirolimus in patients with advanced renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

Prognostic factors of metastatic renal cell carcinoma after failure of immunotherapy: new paradigm from a large phase III trial with shark cartilage extract AE 941

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.003

10.1016/J.UCL.2008.07.003

7 January 2021

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18992615